3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Mantle-Cell
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Hairy Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Classic Follicular Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Cytarabine
3
venetoclax
2
ponatinib
2
merphos
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
nilotinib
1
midostaurin
1
gilteritinib
1
bosutinib
1
blinatumomab
1
asciminib
1
Thiotepa
1
Sirolimus
1
Razoxane
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Melphalan
1
Injections
1
Imatinib Mesylate
1
Gemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
CT-P10
×
30 days
×
Clear all
No trials found.